Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Results First Posted 2025-04-17 and a sponsor-initiated termination notice based on data from other trials are now shown on the study page.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    2%
    Check dated 2025-10-06T05:37:17.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:20.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Minor update: version increased from v3.0.1 to v3.0.2 and the 'Back to Top' link/button was removed; no impact on core content or critical data.
    Difference
    0.1%
    Check dated 2025-09-14T19:23:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T16:16:27.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates related to pulmonary rehabilitation and lung diseases. Notably, specific drug references such as sitravatinib and pembrolizumab have been retained, while many related terms and previous content have been removed.
    Difference
    2%
    Check dated 2025-08-31T12:00:15.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.